Insights That
Move You Forward
Helping you make smarter decisions, avoid costly missteps, and
bring safe, effective products to market with confidence
Trying to Keep Up in May
May’s Trying to Keep Up episodes covered AI diagnostics, RAPID, FDA leadership changes, PCCPs, real-world evidence, cybersecurity, and the evolving future of MedTech regulation—plus the month’s best terrible jokes.
Large vs. Boutique CRO: Which Is Right For Your Clinical Trial?
Choosing between a large CRO and a boutique CRO can significantly impact clinical trial timelines, budgets, and outcomes. This article explores the strengths and limitations of each model, outlines key questions sponsors should ask during vendor selection, and explains why many medical device and combination product companies benefit from a more specialized, hands-on CRO partnership.
Trying to Keep Up in April
April’s Trying to Keep Up episodes covered FDA shifts, clinical strategy decisions, and the realities of working in MedTech right now. This recap breaks down the key takeaways, what they mean for your team, and includes a full roundup of the podcast’s now-signature intro jokes.
The Sales Trap That’s Costing You Clients
In this Q&A recap of The Business of Learning Podcast, NMCG President & Principal Consultant Michael Nilo joins host João Camargo to unpack the “sales trap” that costs expert service providers clients: stopping at “you can’t do that” instead of mapping what is possible. Learn how NMCG blends regulatory rigor with practical, business-savvy guidance for medtech innovators.
Navigating the FDA During a Government Shutdown
When the U.S. government shuts down, FDA operations slow—and medical device companies can face costly delays. In this Global Medical Device Podcast Q&A, NMCG President and former FDA Scientific Reviewer Michael Nilo explains what continues, what stops, and how MedTech leaders can strategically navigate the disruption.